High on innovation, rising demand and rejuvenated confidence to translate opportunities into success, the Indian pharmaceutical industry, which is among the top three in terms of volume globally, is growing leaps and bounds. By an estimate, the industry is all set to expand at a Compound Annual Growth Rate (CAGR) of 16 per cent to $55 billion by 2020. Much of this growth will depend on Indian pharma companies’ capacity to adopt Information Technology to drive their productivity, improve efficiency and maintain cost effectiveness.

In view of increased digital adoption, it is expected that Healthcare Information Technology (IT) market would expand more than 1.5 times by 2020 from its current value of $1 billion to meet the demand from pharma industry as well as other vertical of the healthcare sector….[Read More]


Future Pharma For One World! Be a Global Leader in the Pharma

Past Partners in our Summits

eHealth 2016 Conferences Videos

Social Footprints

Facebook Likes
Linkedin Followers
Twitter Followers
Our Conferences

Powered By

RSS Latest on eHEALTH Pharma

  • Type 2 diabetes, a major health problem in India: study
    Type 2 diabetes is a major health problem in India and the prevalence has been escalating in the past few decades, finds a study conducted by a Mumbai-based diagnostic chain Metropolis Healthcare. In Type 2 diabetes, the body becomes resistant to the normal effects of insulin and gradually loses the capacity to produce enough insulin […]
  • Dr Reddy’s Laboratories launches anti-leukemia injection in US
    Pharmaceutical major Dr Reddy’s Laboratories Ltd has announced that it has launched Clofarabine injection, which is used to treat acute lymphoblastic leukemia (a type of cancer of the white blood cells), in the United States market after getting approval from the US Food and Drug Administration (USFDA). Clofarabine injection is a therapeutic equivalent generic version […]
  • Piramal Pharma Solutions wins prestigious award in Germany
    Piramal Pharma Solutions has won the ‘Industry Partner of the Year’ at the recently held Global Generics and Biosimilars Awards 2017, in Frankfurt, Germany. The awards, among the most coveted recognitions in the pharmaceutical industry, effectively underscore the efforts made by the global generics and biosimilars sectors to make affordable medicines available to more people […]
  • ResCCU initiated at ICU of PD Hinduja Hospital
    Maharashtra Health and Family Minister Deepak Sawant on Saturday launched Responsible Critical Care Units (ResCCU) at PD Hinduja Hospital, Mahim, with an aim to amplify safety and infection control measures in the Intensive Care Unit (ICU) of the hospital. ResCCU offers a set of prescribed guidelines, procedures and evidence backed infection control measures for the […]
  • Nesher Pharma gets FDA nod for ADHD drugs
    A subsidiary of drug firm of Zydus, Nesher Pharmaceuticals, has received FDA approval to market Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets —used in the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy —in strengths of 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, 20 mg, and 30 mg. Zydus said the drug […]

Know More About Pharma CIO 2017